HL

Hakim Lalbhai Saiyed

Active Director Director DIN 07403368
DIN 07403368 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Hakim Lalbhai Saiyed

Data last updated:

Hakim Lalbhai Saiyed is a Director at Resalutem Pharmaceutical Private Limited (since 2016). The company operates in Pharma. Resalutem Pharmaceutical Private Limited reported revenue of ₹11.2 Lakh (FY 2020).

DIN 07403368
Primary Designation Director
Industry Pharma
First Appointment 28 Jan 2016
Oldest Company Age 10 yrs
Largest company Resalutem Pharmaceutical Private Limited · ₹11.2 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jan 20162016₹11.2 Lakh (FY 2020)Active

Board colleagues of Hakim Lalbhai Saiyed

Directorship timeline

Open interactive timeline →
Resalutem Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Hakim Lalbhai Saiyed

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hakim Lalbhai Saiyed

Hakim Lalbhai Saiyed currently holds 1 directorship: Resalutem Pharmaceutical Private Limited (Director, since 28 Jan 2016, revenue ₹11.2 Lakh (FY 2020)).

Hakim Lalbhai Saiyed was first appointed on 28 Jan 2016 as Director at Resalutem Pharmaceutical Private Limited.

The current boards of Hakim Lalbhai Saiyed's companies include Raheem Hakeemsaiyed Saiyed (Resalutem Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available